Dr. Satya Vadlamani
  • Dr. Satya Vadlamani Is The Chairperson And Managing Director Of Murali Krishna Pharma Pvt. Ltd. (Mkppl)
  • Home
  • About Us
  • Blogs
  • In News
Why CPhI Matters: Driving Innovation and Collaboration in the Pharma Sector
adminSeptember 25, 2025

Why CPhI Matters: Driving Innovation and Collaboration in the Pharma Sector

The pharmaceutical industry relies on connections, partnerships, and shared innovation to bring life-saving medicines to patients worldwide. CPhI (Convention on Pharmaceutical Ingredients) stands as the most important

Read More
The Global Pharmaceutical Landscape: Insights from CPhl and Murli Krishna Pharma’s Vision
adminSeptember 17, 2025

The Global Pharmaceutical Landscape: Insights from CPhl and Murli Krishna Pharma’s Vision

The global pharmaceutical industry is seeing tremendous changes in 2025, highlighted by advancements set to be presented at CPhI Frankfurt (Oct 28-30), and the innovative vision of

Read More

Recent Posts

  • When Science Meets a Need: Our Journey with Liposomal Innovations
  • Murli Krishna Pharma – Redefining Health & Beauty through Liposomal Innovation
  • Leadership in Pharma: Dr. Satya Vadlamani’s Vision Reflected at CPhI
  • Why CPhI Matters: Driving Innovation and Collaboration in the Pharma Sector
  • The Global Pharmaceutical Landscape: Insights from CPhl and Murli Krishna Pharma’s Vision

Recent Comments

No comments to show.

Archives

  • October 2025
  • September 2025
  • August 2025
  • April 2025

Categories

  • Blog

Satya Vadlamani - ©2023. All Rights Reserved.